These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 6201961)

  • 1. [Biological and clinical features of alpha 1-antitrypsin with special reference to malignant processes. III].
    Millán Núñez-Cortés J
    Rev Esp Oncol; 1982; 29(2):325-66. PubMed ID: 6201961
    [No Abstract]   [Full Text] [Related]  

  • 2. [Biological and clinical aspects of alpha 1-antitrypsin with special reference to malignant tumor processes II].
    Millán Núñez-Cortés J
    Rev Esp Oncol; 1982; 29(1):77-127 contd. PubMed ID: 6199818
    [No Abstract]   [Full Text] [Related]  

  • 3. [Protease inhibitors, alpha-1-antitrypsin and alpha-2-macroglobulin, in liver processes].
    Tres A; Muñóz JR
    Rev Clin Esp; 1977 Jun; 145(6):407-9. PubMed ID: 70046
    [No Abstract]   [Full Text] [Related]  

  • 4. [Biological and clinical aspects of alpha 1-antitrypsin with special reference to malignant tumor processes].
    Millán Núñez-Cortés J
    Rev Esp Oncol; 1981; 28(4):591-641 contd. PubMed ID: 6764960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pathophysiological analysis of acute phase reactants(I)--Clinical assessment of alpha2/alpha1 ratio obtained by serum protein electrophoresis (author's transl)].
    Kanno T; Kano S; Mimori M; Horii K; Ohtake T
    Rinsho Byori; 1977 Sep; 25(9):763-6. PubMed ID: 72836
    [No Abstract]   [Full Text] [Related]  

  • 6. [Alpha 1-antitrypsin and neoplasms].
    Millán Núñez-Cortés J
    Rev Clin Esp; 1984 Aug 15-31; 174(3-4):65-7. PubMed ID: 6083585
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum protease inhibitors in opisthorchiasis, hepatoma, cholangiocarcinoma, and other liver diseases.
    Changbumrung S; Migasena P; Supawan V; Juttijudata P; Buavatana T
    Southeast Asian J Trop Med Public Health; 1988 Jun; 19(2):299-305. PubMed ID: 2465579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Proteolytic enzyme inhibition and enzyme therapy in chronic nonspecific lung diseases].
    Protsenko VA; Veselov VF; Kanchik IU; Protsenko AV
    Sov Med; 1983; (3):7-11. PubMed ID: 6190232
    [No Abstract]   [Full Text] [Related]  

  • 9. Protease inhibitor and gastric cancer.
    Tsumoto S; Oyabu H; Kageyama T
    Bull Osaka Med Sch; 1983 Jul; 29(1):18-26. PubMed ID: 6204707
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunochemical diagnostis of gastrointestinal diseases (with special consideration of tumor immunology)].
    Tilz ZP; Buffe D; Rimbaut C
    Med Klin; 1973 Jul; 68(30):994-9. PubMed ID: 4125217
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of a method of combined determination of the activity of the trypsin-like proteinases, alpha 1-antitrypsin and alpha 2-macroglobulin, in a gastroenterology clinic].
    Kariagina IIu; Zarembskiĭ RA; Baliabina MD
    Lab Delo; 1990; (2):10-3. PubMed ID: 1692355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Proteolytic activity and trypsin inhibitor content in the blood serum in nonspecific lung diseases].
    Syromiatnikova NV; Goncharova VA; Zybina NN; Kutova AP
    Sov Med; 1978 Apr; (4):60-4. PubMed ID: 306685
    [No Abstract]   [Full Text] [Related]  

  • 13. Does the concentration of alpha 1-proteinase inhibitor reflect the transformation of liver cirrhosis to liver carcinoma?
    Dabrowska M; Mantur M; Panasiuk A; Prokopowicz J
    Neoplasma; 1997; 44(5):305-7. PubMed ID: 9473790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The trypsin-antitrypsin system and the content of blood middle-molecular peptides in experimental traumatic shock].
    Gudumak VS; Marchenko VP; Nigulianu VI
    Patol Fiziol Eksp Ter; 1990; (2):30-2. PubMed ID: 1696370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Determination of the activity of trypsin and its inhibitors in biological fluids].
    Chernikova LG
    Lab Delo; 1971; 1():38-40. PubMed ID: 4110726
    [No Abstract]   [Full Text] [Related]  

  • 16. [Enzyme values in the duodenal juice in infants and small children].
    Zujović J; Milosević V; Petrović Lj; Janković I; Zivancević Lj
    Srp Arh Celok Lek; 1968 Mar; 96(3):263-8. PubMed ID: 5192196
    [No Abstract]   [Full Text] [Related]  

  • 17. Hepatocarcinogenesis is the sequel to hepatitis in Z#2 alpha 1-antitrypsin transgenic mice: histopathological and DNA ploidy studies.
    Geller SA; Nichols WS; Kim S; Tolmachoff T; Lee S; Dycaico MJ; Felts K; Sorge JA
    Hepatology; 1994 Feb; 19(2):389-97. PubMed ID: 8294096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Blood proteolytic enzyme inhibitors and their clinical study].
    Veremeenko KN; Kizim AI
    Vopr Med Khim; 1975; 21(1):5-13. PubMed ID: 1091093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Status of the trypsin-trypsin inhibitor system in pneumonia-related toxemia in children].
    Sharyshev IuS
    Pediatriia; 1987; (10):18-21. PubMed ID: 2447555
    [No Abstract]   [Full Text] [Related]  

  • 20. Objective changes in trypsin, alpha 1-antitrypsin, and alpha 2-macroglobulin values as a result of sodium fluoride treatment in patients with otosclerosis.
    Causse JR; Uriel J; Berges J; Bretlau P; Shambaugh GE; Causse JB
    Am J Otol; 1985 Jan; 6(1):38-42. PubMed ID: 2579564
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.